NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

自體免疫疾病診斷的全球市場分析:各類型、各產品、各技術、各地區的未來預測

Global Autoimmune Disease Diagnostics Market Size study, by Type, Product, Technology and Regional Forecasts 2020-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 933864
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
自體免疫疾病診斷的全球市場分析:各類型、各產品、各技術、各地區的未來預測 Global Autoimmune Disease Diagnostics Market Size study, by Type, Product, Technology and Regional Forecasts 2020-2026
出版日期: 2020年04月10日內容資訊: 英文
簡介

全球自體免疫疾病診斷的市場規模在2019年估算達到約37億美元,再加上2019∼2026年預計將以9.20%以上的速度成長。在市場成長的背景中,有自體免疫疾病 - 全身性紅斑性狼瘡,類風濕性關節炎等 - 的患病者增加,及生物感應器的效用高漲,自體免疫疾病的認識的提高等要素。

本報告提供全球自體免疫疾病診斷的相關市場相關分析,市場基本結構 (價值鏈等) 和主要的促進、阻礙因素,整體市場規模趨勢預測 (今後8年份),各類型、各產品、各技術及各地區詳細趨勢,主要企業的簡介、市場佔有率等資訊彙整,為您概述為以下內容。

第1章 摘要整理

第2章 全球自體免疫疾病診斷市場:定義和範圍

第3章 全球自體免疫疾病診斷市場:市場動態

  • 自體免疫疾病診斷對市場的影響度分析
    • 推動市場要素
    • 市場課題
    • 市場機會

第4章 全球自體免疫疾病診斷市場:產業分析

  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 新加入企業的威脅
    • 替代品的威脅
    • 企業間競爭
    • 波特的五力分析:未來方法
  • PEST分析
    • 政治要素
    • 經濟要素
    • 社會要素
    • 技術性要素
  • 投資/引進模式
  • 分析師的建議與結論

第5章 全球自體免疫疾病診斷市場:各類型

  • 市場概況
  • 市場成果值,各類型:未來性分析
  • 市場估計值、預測值:各類型 (以金額為準)
  • 子區隔分析
    • 局部性自體免疫疾病診斷
    • 全身性自體免疫疾病診斷

第6章 全球自體免疫疾病診斷市場:各產品

  • 市場概況
  • 市場成果值,各產品:未來性分析
  • 市場估計值、預測值:各產品 (以金額為準)
  • 子區隔分析
    • 藥物
    • 治療、監測設備
    • 診斷設備

第7章 全球自體免疫疾病診斷市場:各技術

  • 市場概況
  • 市場成果值,各技術:未來性分析
  • 市場估計值、預測值:各技術 (以金額為準)
  • 子區隔分析
    • 牙橋治療
    • 緩解疾病性抗風濕藥 (DMARD)
    • 局部療法
    • 光線療法
    • 蠕蟲療法
    • 基因重組技術

第8章 全球自體免疫疾病診斷市場:各地區分析

  • 自體免疫疾病診斷市場:各地區的市場概況
  • 北美市場
    • 美國
    • 加拿大
  • 歐洲市場
    • 英國
    • 德國
    • 其他
  • 亞太地區市場
    • 中國
    • 印度
    • 日本
    • 其他
  • 南美市場
    • 巴西
    • 墨西哥
  • 其他國家的市場 (RoW)

第9章 企業資料

  • 主要市場策略
  • 企業簡介
    • Thermo Fisher Scientific
    • Siemens Healthineers
    • Abbott Laboratories
    • Danaher Corporation
    • Bio-Rad Laboratories, Inc.
    • Grifols
    • Trinity Biotech
    • Werfen
    • HYCOR Biomedical
    • Exagen Inc.

第13章 調查方法

目錄

Global Autoimmune Disease Diagnostics Market is valued approximately USD 3.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2019-2026. The Autoimmune diseases refer to body's abnormal immune response resulting in the production of antibodies that impact or attack own cells & tissues which leads to destruction and deterioration of healthy tissues. In the present scenario, there are around 80 types of autoimmune diseases such as systematic lupus erythematosus and rheumatoid arthritis prevalent in the global scenario. The Autoimmune disease diagnostics market is primarily driven owing to a high prevalence of autoimmune diseases, escalating awareness, about autoimmune diseases, rise in the number of growth activities on autoimmune diseases and escalating utility of biosensors for autoimmune disease diagnostics. The high incidence and prevalence of autoimmune diseases is acting as a key factor in the development and growth of autoimmune disease diagnostics market. For instance: according to the American Autoimmune Related Diseases Association (AARDA), the autoimmune disease impacts around 50 million individuals residing in both urban and semi-urban provinces among which 75% are females in the United States resulting in fueling the demand and adoption of autoimmune disease diagnostics market. However, high capital requirements impede the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Autoimmune Disease Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high incidence & prevalence of autoimmune diseases and growth in number of research activities on autoimmune diseases. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising aging population along with use of biosensors for autoimmune disease diagnosis would create lucrative growth prospects for the Autoimmune Disease Diagnostics market across Asia-Pacific region.

Major market player included in this report are:

Thermo Fisher Scientific

Siemens Healthineers

Abbott Laboratories

Danaher Corporation

Bio-Rad Laboratories, Inc.

Grifols

Trinity Biotech

Werfen

HYCOR Biomedical

Exagen Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Localized Autoimmune Disease Diagnostic

Systemic Autoimmune Disease Diagnostic

By Product:

Drugs

Therapeutic & Monitoring Equipment

Diagnostic Equipment

By Technology:

Bridge Therapy

Disease-Modifying Antirheumatic Drugs (DMARD)

Topical Therapy

Phototherapy

Helminthic Therapy

Recombinant Technology

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017, 2018

Base year - 20198

Forecast period - 2020 to 2026

Target Audience of the Global Autoimmune Disease Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
    • 1.2.1. Autoimmune Disease Diagnostics Market, by Region, 2018-2026 (USD Billion)
    • 1.2.2. Autoimmune Disease Diagnostics Market, by Type, 2018-2026 (USD Billion)
    • 1.2.3. Autoimmune Disease Diagnostics Market, by Product, 2018-2026 (USD Billion)
    • 1.2.4. Autoimmune Disease Diagnostics Market, by Technology, 2018-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Autoimmune Disease Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Autoimmune Disease Diagnostics Market Dynamics

  • 3.1. Autoimmune Disease Diagnostics Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Autoimmune Disease Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Autoimmune Disease Diagnostics Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Autoimmune Disease Diagnostics Market by Type, Performance - Potential Analysis
  • 5.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
  • 5.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
    • 5.4.1. Localized Autoimmune Disease Diagnostic
    • 5.4.2. Systemic Autoimmune Disease Diagnostic
    • 5.4.3.

Chapter 6. Global Autoimmune Disease Diagnostics Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Autoimmune Disease Diagnostics Market by Product, Performance - Potential Analysis
  • 6.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Product, 2016-2026 (USD Billion)
  • 6.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Drugs
    • 6.4.2. Therapeutic & Monitoring Equipment
    • 6.4.3. Diagnostic Equipment

Chapter 7. Global Autoimmune Disease Diagnostics Market, by Technology

  • 7.1. Market Snapshot
  • 7.2. Global Autoimmune Disease Diagnostics Market by Technology, Performance - Potential Analysis
  • 7.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Technology, 2016-2026 (USD Billion)
  • 7.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Bridge Therapy
    • 7.4.2. Disease-Modifying Antirheumatic Drugs (DMARD)
    • 7.4.3. Topical Therapy
    • 7.4.4. Phototherapy
    • 7.4.5. Helminthic Therapy
    • 7.4.6. Recombinant Technology

Chapter 8. Global Autoimmune Disease Diagnostics Market, Regional Analysis

  • 8.1. Autoimmune Disease Diagnostics Market, Regional Market Snapshot
  • 8.2. North America Autoimmune Disease Diagnostics Market
    • 8.2.1. U.S. Autoimmune Disease Diagnostics Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 8.2.1.2. Product breakdown estimates & forecasts, 2016-2026
      • 8.2.1.3. Technology breakdown estimates & forecasts, 2016-2026
    • 8.2.2. Canada Autoimmune Disease Diagnostics Market
  • 8.3. Europe Autoimmune Disease Diagnostics Market Snapshot
    • 8.3.1. U.K. Autoimmune Disease Diagnostics Market
    • 8.3.2. Germany Autoimmune Disease Diagnostics Market
    • 8.3.3. Rest of Europe Autoimmune Disease Diagnostics Market
  • 8.4. Asia-Pacific Autoimmune Disease Diagnostics Market Snapshot
    • 8.4.1. China Autoimmune Disease Diagnostics Market
    • 8.4.2. India Autoimmune Disease Diagnostics Market
    • 8.4.3. Japan Autoimmune Disease Diagnostics Market
    • 8.4.4. Rest of Asia Pacific Autoimmune Disease Diagnostics Market
  • 8.5. Latin America Autoimmune Disease Diagnostics Market Snapshot
    • 8.5.1. Brazil Autoimmune Disease Diagnostics Market
    • 8.5.2. Mexico Autoimmune Disease Diagnostics Market
  • 8.6. Rest of The World Autoimmune Disease Diagnostics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Thermo Fisher Scientific
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Siemens Healthineers
    • 9.2.3. Abbott Laboratories
    • 9.2.4. Danaher Corporation
    • 9.2.5. Bio-Rad Laboratories, Inc.
    • 9.2.6. Grifols
    • 9.2.7. Trinity Biotech
    • 9.2.8. Werfen
    • 9.2.9. HYCOR Biomedical
    • 9.2.10. Exagen Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

List of Tables

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET
  • TABLE 3. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 22. U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 23. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 25. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 26. UK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. UK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. UK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 29. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 32. ROE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. ROE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. ROE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 35. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 38. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 41. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 44. ROAPAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. ROAPAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. ROAPAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 48. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 51. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. ROLA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 54. ROLA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. ROLA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. ROW AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. ROW AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. ROW AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

List of Figures

  • FIG 1. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2026
  • FIG 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 16. EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 17. ASIA PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 18. LATIN AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 19. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)